AOD-9604

Fat LossResearch Use Only

Also known as: AOD9604, hGH fragment 176-191 analog

AOD-9604 is a modified fragment derived from the C-terminal region of human growth hormone, commonly referenced in lipolysis research literature. Studies describe its investigation for effects on fat metabolism without the broader growth-promoting actions of full-length growth hormone. It is frequently discussed as a research compound in metabolic contexts.

Typical range (research)

Research literature commonly references amounts in the ~250–300 mcg range as a reference point

Half-life

~30 minutes (reported)

Route

Subcutaneous (research)

Common use

Fat-metabolism research

Common vial sizes

2 mg · 5 mg

Storage

Store lyophilized powder refrigerated (2–8°C) and protected from light; once reconstituted, keep refrigerated and use within the timeframe supported by stability data.

Stacking notes

Sometimes referenced in research discussions alongside other metabolic compounds; combination use is not well characterized in the literature.

Reported side effects

Injection-site reactions (reported)Generally reported as well tolerated in studies

Regulatory note: Not approved as a therapeutic drug in Canada or the US; investigational status. Research-grade material is not for human use.

Calculate a dose →

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Not for human or veterinary use. Consult a licensed physician.